NDC 31722-155

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-155Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0155Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
31722-155-01	31722015501	100 TABLET in 1 BOTTLE (31722-155-01)Marketed from May 10, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate
Generic name (nonproprietary): dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Active ingredients: Amphetamine aspartate monohydrate — 1.25 mg/1Amphetamine sulfate — 1.25 mg/1Dextroamphetamine sulfate — 1.25 mg/1Dextroamphetamine saccharate — 1.25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213709
Marketing start: May 10, 2021
Listing expires: Dec 31, 2026
DEA schedule: CII
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)Central Nervous System Stimulation (Physiologic effect)Central Nervous System Stimulation (Physiologic effect)Central Nervous System Stimulation (Physiologic effect)
Identifiers: Product ID 31722-155_eac552ea-6080-4935-a154-39ab177ef350SPL ID eac552ea-6080-4935-a154-39ab177ef350SPL set ID 430cccec-1679-4225-8c86-92d746153b38RxCUI 541363, 541878, 541892, 577957, 577961, 687043, 1009145UNII O1ZPV620O4, G83415V073, 6DPV8NK46S, JJ768O327NUPC 0331722158015, 0331722155014, 0331722156011, 0331722159012, 0331722157018, 0331722164016, 0331722163019
Pharmacologic class: Central Nervous System Stimulant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722015501 followed by a unit qualifier and the quantity

Package 31722-0155-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 28, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy. Attention Deficit Hyperactivity Disorder (ADHD) A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-IV ® ) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. The symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. The symptoms must not be…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213709

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213709
Product	Strength	Form · route	Labeler	Product NDC
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	Amphetamine aspartate monohydrate 3.125 mg/1 + 3 more ingredients	TabletOral	Camber Pharmaceuticals, Inc.	31722-158
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	Amphetamine aspartate monohydrate 1.875 mg/1 + 3 more ingredients	TabletOral	Camber Pharmaceuticals, Inc.	31722-156
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	Amphetamine aspartate monohydrate 2.5 mg/1 + 3 more ingredients	TabletOral	Camber Pharmaceuticals, Inc.	31722-157
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	Amphetamine aspartate monohydrate 3.75 mg/1 + 3 more ingredients	TabletOral	Camber Pharmaceuticals, Inc.	31722-159
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	Amphetamine aspartate monohydrate 5 mg/1 + 3 more ingredients	TabletOral	Camber Pharmaceuticals, Inc.	31722-163
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	Amphetamine aspartate monohydrate 7.5 mg/1 + 3 more ingredients	TabletOral	Camber Pharmaceuticals, Inc.	31722-164

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate NDC 31722-155